These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 22178245)

  • 1. Activity of ultra-low doses of antibodies to gamma-interferon against lethal influenza A(H1N1)2009 virus infection in mice.
    Tarasov SA; Zarubaev VV; Gorbunov EA; Sergeeva SA; Epstein OI
    Antiviral Res; 2012 Feb; 93(2):219-224. PubMed ID: 22178245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.
    Don ЕS; Emelyanova AG; Yakovleva NN; Petrova NV; Nikiforova MV; Gorbunov EA; Tarasov SА; Morozov SG; Epstein ОI
    J Med Virol; 2017 May; 89(5):759-766. PubMed ID: 27769099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral activity of Anaferon (pediatric formulation) in mice infected with pandemic influenza virus A(H1N1/09).
    Shishkina LN; Skarnovich MO; Kabanov AS; Sergeev AA; Olkin SE; Tarasov SA; Belopolskaya MV; Sergeeva SA; Epstein OI; Malkova EM; Stavsky EA; Drozdov IG
    Bull Exp Biol Med; 2010 Oct; 149(5):612-4. PubMed ID: 21165400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lethal synergism of 2009 pandemic H1N1 influenza virus and Streptococcus pneumoniae coinfection is associated with loss of murine lung repair responses.
    Kash JC; Walters KA; Davis AS; Sandouk A; Schwartzman LM; Jagger BW; Chertow DS; Li Q; Kuestner RE; Ozinsky A; Taubenberger JK
    mBio; 2011; 2(5):. PubMed ID: 21933918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combinations of favipiravir and peramivir for the treatment of pandemic influenza A/California/04/2009 (H1N1) virus infections in mice.
    Tarbet EB; Maekawa M; Furuta Y; Babu YS; Morrey JD; Smee DF
    Antiviral Res; 2012 Apr; 94(1):103-10. PubMed ID: 22429564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Study of efficacy of anaferon pediatric in mice infected by pandemic influenza virus A(H1N1/09)v].
    Shishkina LI; Skarnovich MO; Kabanov AS; Sergeev AA; Tarasov SA; Sergeeva SA; Épshteĭn ; Malkova EM; Stavskiĭ EA; Drozdov IG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (1):83-6. PubMed ID: 21446173
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammalian pathogenesis of oseltamivir-resistant pandemic (H1N1) 2009 influenza virus isolated in South Korea.
    Kwon D; Shin K; Kim SJ; Lee JY; Kang C
    Virus Res; 2014 Jun; 185():41-6. PubMed ID: 24657788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibodies against swine influenza virus neutralize the pandemic influenza virus A/H1N1.
    Tsukamoto M; Hiroi S; Adachi K; Kato H; Inai M; Konishi I; Tanaka M; Yamamoto R; Sawa M; Handharyani E; Tsukamoto Y
    Mol Med Rep; 2011; 4(2):209-14. PubMed ID: 21468553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polygalasaponin F treats mice with pneumonia induced by influenza virus.
    Ye Y; Wang H; Liu J; Zhao F; Xu P
    Inflammopharmacology; 2020 Feb; 28(1):299-310. PubMed ID: 31446589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prior infected influenza virus could protect mice from challenge of lethal influenza virus].
    Liu LQ; Li Z; Zhu Y; Shu YL
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2012 Dec; 26(6):405-8. PubMed ID: 23627014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type I interferon limits influenza virus-induced acute lung injury by regulation of excessive inflammation in mice.
    Arimori Y; Nakamura R; Yamada H; Shibata K; Maeda N; Kase T; Yoshikai Y
    Antiviral Res; 2013 Sep; 99(3):230-7. PubMed ID: 23721943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-influenza virus effects of crude phenylethanoid glycosides isolated from ligustrum purpurascens via inducing endogenous interferon-γ.
    Hu XP; Shao MM; Song X; Wu XL; Qi L; Zheng K; Fan L; Liao CH; Li CY; He J; Hu YJ; Wu HQ; Li SH; Zhang J; Zhang FX; He ZD
    J Ethnopharmacol; 2016 Feb; 179():128-36. PubMed ID: 26190352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
    Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
    Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
    Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [In vitro and in vivo effects of a long-acting anti-influenza agent CS-8958 (laninamivir octanoate, Inavir) against pandemic (H1N1) 2009 influenza viruses].
    Kubo S; Kakuta M; Yamashita M
    Jpn J Antibiot; 2010 Oct; 63(5):337-46. PubMed ID: 21268406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination of ribavirin and reduning protects mice against severe pneumonia induced by H1N1 influenza a virus.
    Ma Y; Zhang W; Zhao Z; Li M; Liu J; Wang Y
    J Tradit Chin Med; 2016 Apr; 36(2):181-6. PubMed ID: 27400472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a fully human monoclonal antibody against multiple influenza A viral strains in mice and a pandemic H1N1 strain in nonhuman primates.
    Song A; Myojo K; Laudenslager J; Harada D; Miura T; Suzuki K; Kuni-Kamochi R; Soloff R; Ohgami K; Kanda Y
    Antiviral Res; 2014 Nov; 111():60-8. PubMed ID: 25218949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vivo efficacy of Ingavirin against pandemic A (H1N1/09)v influenza virus].
    Shishkina LN; Nebol'sin VE; Skarnovich MO; Kabanov AS; Sergeev AA; Erdyneeva UB; Serova OA; Demina OK; Agafonov AP; Stavskiĭ EA; Drozdov IG
    Antibiot Khimioter; 2010; 55(5-6):32-5. PubMed ID: 21033472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The combination of oseltamivir with azithromycin does not show additional benefits over oseltamivir monotherapy in mice infected with influenza A(H1N1)pdm2009 virus.
    Fage C; Pizzorno A; Rhéaume C; Abed Y; Boivin G
    J Med Virol; 2017 Dec; 89(12):2239-2243. PubMed ID: 28792077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geniposide demonstrates anti-inflammatory and antiviral activity against pandemic A/Jiangsu/1/2009 (H1N1) influenza virus infection in vitro and in vivo.
    Zhang Y; Yao J; Qi X; Liu X; Lu X; Feng G
    Antivir Ther; 2017; 22(7):599-611. PubMed ID: 28272019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.